Targeting the interleukin-11 receptor alpha in metastatic prostate cancer: A first-in-man study

Autor:	Pasqualini, R, Millikan, RE, Christianson, DR, Cardo-Vila, M, Driessen, WHP, Giordano, RJ, Hajitou, A, Hoang, AG, Wen, S, Barnhart, KF, Baze, WB, Marcott, VD, Hawke, DH, Do, K-A, Navone, NM, Efstathiou, E, Troncoso, P, Lobb, RR, Logothetis, CJ, Arap, W
Jazyk:	angličtina
Rok vydání:	2014
Předmět:	EXPRESSION Male Maximum Tolerated Dose INCREASED SURVIVAL Antineoplastic Agents Bone Neoplasms GUIDELINES Kidney vascular targeting Drug Administration Schedule DELIVERY Humans Interleukin-11 Receptor alpha Subunit Oncology & Carcinogenesis SM-153 LEXIDRONAM Aged DOCETAXEL Aged 80 and over Science & Technology bone metastasis-targeting peptidomimetic-11 clinical trial ABIRATERONE Middle Aged prostate cancer Prostatic Neoplasms Castration-Resistant Proteinuria PHASE-I Treatment Outcome Oncology CELLS DISPLAY interleukin-11 receptor alpha Peptides Life Sciences & Biomedicine 1112 Oncology And Carcinogenesis interleukin-11 receptor α
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1032::64111078b8be7b3e651fefa1406c3d8a http://hdl.handle.net/10044/1/30711 Zobrazit plný text záznamu